A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors

MLA

Oren J, Becher, et al. “A Phase I Study of Perifosine with Temsirolimus for Recurrent Pediatric Solid Tumors.” Pediatric Bloodcancer, vol. 64, no. 7, May 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........aa09c249cf39168174918bb7e4e3389e&authtype=sso&custid=ns315887.

APA

Oren J, B., Stephen W, G., Yasmin, K., David C, L., Sofia, H., Kevin C, D. B., Jill M, K., Jason T, H., Shakeel, M., Leonard H, W., Kim, K., Ivan, S., & Ira J, D. (2016). A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors. Pediatric Bloodcancer, 64(7).

Chicago

Oren J, Becher, Gilheeney Stephen W, Khakoo Yasmin, Lyden David C, Haque Sofia, De Braganca Kevin C, Kolesar Jill M, et al. 2016. “A Phase I Study of Perifosine with Temsirolimus for Recurrent Pediatric Solid Tumors.” Pediatric Bloodcancer 64 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........aa09c249cf39168174918bb7e4e3389e&authtype=sso&custid=ns315887.